Pre-Mixing tPA: Moving Past Gestalt (P2.303)

Conclusions: While pre-mixing tPA does not incur financial risk as drug manufacturers replace unused vials without cost, stroke centers remain wary of wasting the drug. We believe succinct criteria can reduce avoidable tPA waste, allowing health care providers to remain fiscally responsible while ensuring AIS patients are treated as fast as possible.Disclosure: Dr. McCarthy has nothing to disclose. Dr. Caputo has nothing to disclose. Dr. Whaley has received personal compensation for activities with Clinical Data Management/Neurobase and Genentech. Dr. Fanale has received personal compensation for activities with Genentech, Inc as a speaker. Dr. Bar-Or has nothing to disclose.
Source: Neurology - Category: Neurology Authors: Tags: Acute Therapy: IV t-PA Source Type: research